Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NTT Docomo is Japan’s largest mobile telecommunications operator. While not a traditional life sciences or pharmaceutical company, it has developed significant capabilities in digital healthcare through mobile-based platforms that use artificial intelligence to analyze user behavior and physiological data. Its “Kenko Mileage” service uses smartphone logs to assess frailty risk among elderly users—commercialized across over 120 municipalities—and provides personalized advice based on behavioral indicators. The company also collaborates on precision medicine infrastructure through the broader NTT Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NTT Docomo.